These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9367469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM, Liao E, Hohneker K, Turpin S, Henry MM, Selinger K, Hsyu PH, Boucher RC, Knowles MR, Dukes GE.
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [Abstract] [Full Text] [Related]

  • 3. Deposition, clearance, and effects of aerosolized amiloride in sheep airways.
    Mentz WM, Brown JB, Friedman M, Stutts MJ, Gatzy JT, Boucher RC.
    Am Rev Respir Dis; 1986 Nov; 134(5):938-43. PubMed ID: 3777691
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH, O'Doherty MJ, Graham A, Page CJ, Blower P, Geddes DM, Nunan TO.
    Thorax; 1991 Oct; 46(10):717-21. PubMed ID: 1750018
    [Abstract] [Full Text] [Related]

  • 5. Acute cardiovascular and pulmonary effects of intravenous and aerosolized amiloride in the dog.
    Boucher RC, James MK, Friedman M, Fullton J, Pimmel R, Gatzy JT.
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):264-75. PubMed ID: 3824385
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis].
    Faurisson F, Dessanges JF, Grimfeld A, Beaulieu R, Kitzis MD, Peytavin G, Lefevre JP, Farinotti R, Sautegeau A.
    Rev Mal Respir; 1996 Feb; 13(2):155-62. PubMed ID: 8711234
    [Abstract] [Full Text] [Related]

  • 7. Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose.
    Faurisson F, Dessanges JF, Grimfeld A, Beaulieu R, Kitzis MD, Peytavin G, Lefebvre JP, Farinotti R, Sautegeau A.
    Respiration; 1995 Feb; 62 Suppl 1():13-8. PubMed ID: 7792434
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer.
    Köhler E, Sollich V, Schuster-Wonka R, Hühnerbein J.
    J Aerosol Med; 2003 Feb; 16(1):37-46. PubMed ID: 12737683
    [Abstract] [Full Text] [Related]

  • 10. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM, King M, Helfesrieder R, Köhler D, Matthys H.
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [Abstract] [Full Text] [Related]

  • 11. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
    Hofmann T, Senier I, Bittner P, Hüls G, Schwandt HJ, Lindemann H.
    J Aerosol Med; 1997 Mar; 10(2):147-58. PubMed ID: 10168532
    [Abstract] [Full Text] [Related]

  • 12. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S, Winnips C, Edelman J, Kappeler D, Herpich C, Ehlich H, Zanker D, Kietzig C, Sommerer K.
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [Abstract] [Full Text] [Related]

  • 13. Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.
    Rasgado-Flores H, Krishna Mandava V, Siman H, Van Driessche W, Pilewski JM, Randell SH, Bridges RJ.
    Am J Physiol Cell Physiol; 2013 Dec 01; 305(11):C1114-22. PubMed ID: 23986197
    [Abstract] [Full Text] [Related]

  • 14. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.
    Sood N, Bennett WD, Zeman K, Brown J, Foy C, Boucher RC, Knowles MR.
    Am J Respir Crit Care Med; 2003 Jan 15; 167(2):158-63. PubMed ID: 12411282
    [Abstract] [Full Text] [Related]

  • 15. Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients.
    Köhler E, Sollich V, Schuster-Wonka R, Jorch G.
    J Aerosol Med; 2005 Jan 15; 18(4):386-95. PubMed ID: 16379615
    [Abstract] [Full Text] [Related]

  • 16. [Amiloride inhalation therapy in mucoviscidosis].
    Lindemann H.
    Monatsschr Kinderheilkd; 1993 May 15; 141(5):392-4. PubMed ID: 8326957
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ, Sabater JR, Zamurs A, Smith RT, Paradiso AM, Hopkins S, Abraham WM, Boucher RC.
    J Pharmacol Exp Ther; 2004 Dec 15; 311(3):929-38. PubMed ID: 15273255
    [Abstract] [Full Text] [Related]

  • 18. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW, Boucher RC.
    N Engl J Med; 1990 Apr 26; 322(17):1189-94. PubMed ID: 2157983
    [Abstract] [Full Text] [Related]

  • 19. Comparison of three commercial ultrasonic nebulizers.
    Katial RK, Reisner C, Buchmeier A, Bartelson BB, Nelson HS.
    Ann Allergy Asthma Immunol; 2000 Feb 26; 84(2):255-61. PubMed ID: 10719784
    [Abstract] [Full Text] [Related]

  • 20. An alternative aerosol delivery system for amiloride.
    Everard ML, Devadason SG, Sunderland VB, Le Souef PN.
    Thorax; 1995 May 26; 50(5):517-9. PubMed ID: 7597664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.